The pharma has received ANDA final approval from the US FDA for Zolmitriptan Orally Disintegrating Tablets, 2.5 mg and 5 mg, the generic version of Zomig-ZMT(of Astra Zeneca), which is used for acute treatment of migraine headaches in adults.
| Subscribe To Our Free Newsletter |
